Author

C. Stark

h-index 7 View on Semantic Scholar

We have 3 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Memory and Plasma pTau217 Refine Prognosis in Down Syndrome.

Individuals with Down syndrome (DS) are at high risk for Alzheimer's disease (AD), yet accessible tools for routine clinical screening of AD in individuals with DS remain limited. Using data from the Alzheimer Biomarker Consortium-Down Syndrome (ABC-DS), we show that integrating plasma pTau217 with performance on the m...

C. Vanderlip, S. Hartley, S. Krinsky-McHale et al. · Annals of Neurology · 0 citations

Open access Sep 2026

Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer's disease

Amyloid positivity does not reliably predict near‐term cognitive decline in preclinical Alzheimer's disease (AD). We tested whether digital cognitive phenotyping improves prognostic precision.

C. Vanderlip, C. Stark · Alzheimer's & Dementia · 1 citation

Jul 2026

Modernizing cognitive assessment in Alzheimer’s disease

Digital cognitive assessments that target Alzheimer’s-disease-vulnerable systems can detect earlier functional change and strengthen plasma-biomarker prognosis.

C. Vanderlip, Craig E. L. Stark · Nature Aging · 0 citations